{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:18:18Z","timestamp":1792649898371,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:00:00Z","timestamp":1688083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.clinthera.2023.06.009","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T15:45:55Z","timestamp":1689090355000},"page":"797-801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Phage Therapy for Diabetic Foot Infection: A Case Series"],"prefix":"10.1016","volume":"45","author":[{"given":"Matthew J.","family":"Young","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley M.L.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Merabishvilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Pirnay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0981-1913","authenticated-orcid":false,"given":"Joshua D.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2023.06.009_bib0001","doi-asserted-by":"crossref","unstructured":"Lin X, Xu Y, Pan X, et\u00a0al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020;10:14790. doi:10.1038\/s41598-020-71908-9","DOI":"10.1038\/s41598-020-71908-9"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0002","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence","volume":"376","author":"Armstrong","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0003","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/dme.13537","article-title":"Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study","volume":"35","author":"Ndosi","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0004","unstructured":"Lower Limb Amputations: 26,378 Diabetes-Related Lower Limb Amputations in the Last Three Years [Diabetes UK website]. 2018. Available at: https:\/\/www.diabetes.org.uk\/about_us\/news\/lower-limb-amputations. Accessed October 21, 2021."},{"key":"10.1016\/j.clinthera.2023.06.009_bib0005","article-title":"Bacterial diversity, antibiotic resistance, and the risk of lower limb amputation in younger and older individuals with diabetic foot infection","author":"D\u00f6rr","year":"2021","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0006","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1186\/s12879-021-06516-7","article-title":"The microbiology of diabetic foot infections: a meta-analysis","volume":"21","author":"Macdonald","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0007","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-12-394438-2.00001-3","article-title":"Phage therapy\u2014history from Twort and d'Herelle through Soviet experience to current approaches","volume":"83","author":"Chanishvili","year":"2012","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0008","series-title":"Bacteriophages","first-page":"1","article-title":"Current updates from the long-standing phage research centers in Georgia, Poland, and Russia","author":"Mi\u0119dzybrodzki","year":"2018"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0009","doi-asserted-by":"crossref","unstructured":"Maimaiti Z, Li Z, Xu C, Chen J, Chai W. Global Trends and Hotspots of Phage Therapy for Bacterial Infection: a Bibliometric Visualized Analysis from 2001 to 2021 [Front Microbiol. online]. 2023. Available at: https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.1067803. Accessed April 23, 2023.","DOI":"10.3389\/fmicb.2022.1067803"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(21)00612-5","article-title":"Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review","author":"Uyttebroek","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0011","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3390\/antibiotics11101340","article-title":"The safety and efficacy of phage therapy: a systematic review of clinical and safety trials","volume":"11","author":"Stacey","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0012","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3390\/antibiotics9110754","article-title":"The safety and efficacy of phage therapy for superficial bacterial infections: a systematic review","volume":"9","author":"Steele","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0014","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ijantimicag.2018.09.006","article-title":"Bacteriophage Sb-1 enhances antibiotic activity against biofilm, degrades exopolysaccharide matrix and targets persisters of Staphylococcus aureus","volume":"52","author":"Tkhilaishvili","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0015","doi-asserted-by":"crossref","first-page":"E1580","DOI":"10.3390\/microorganisms8101580","article-title":"Biofilms in diabetic foot ulcers: significance and clinical relevance","volume":"8","author":"Pouget","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0016","unstructured":"Scottish Health Technologies Group HIS. SHTG Recommendation [SHTG website]. 2023. https:\/\/shtg.scot\/our-advice\/bacteriophage-therapy-for-patients-with-difficult-to-treat-bacterial-infections. Accessed February 24, 2023."},{"key":"10.1016\/j.clinthera.2023.06.009_bib0017","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02071-21","article-title":"Antibacterial Resistance Leadership Group. Considerations for the use of phage therapy in clinical practice","author":"Suh","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0018","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1093\/cid\/cis346","article-title":"2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections","volume":"54","author":"Lipsky","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0019","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/v10020064","article-title":"The magistral phage","volume":"10","author":"Pirnay","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1371\/journal.pone.0004944","article-title":"Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials","volume":"4","author":"Merabishvili","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0021","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/v13091785","article-title":"Bacteriophage rescue therapy of a vancomycin-resistant Enterococcus faecium infection in a one-year-old child following a third liver transplantation","volume":"13","author":"Paul","year":"2021","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0022","doi-asserted-by":"crossref","first-page":"8278","DOI":"10.3390\/ijms22158278","article-title":"Biofilms in diabetic foot ulcers: impact, risk factors and control strategies","volume":"22","author":"Afonso","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0023","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5194\/jbji-7-61-2022","article-title":"Short and oral antimicrobial therapy for diabetic foot infection: a narrative review of current knowledge","volume":"7","author":"Maurer","year":"2022","journal-title":"J Bone Jt Infect"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0024","unstructured":"Defining Research [Health Research Authority website]. 2017. Available at: http:\/\/www.hra-decisiontools.org.uk\/research\/docs\/definingresearchtable_oct2017-1.pdf. Accessed September 26, 2022."},{"key":"10.1016\/j.clinthera.2023.06.009_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243947","article-title":"Patient perceptions of phage therapy for diabetic foot infection","volume":"15","author":"Macdonald","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0026","first-page":"30","article-title":"Phage therapy for diabetic foot infection","volume":"25","author":"Young","year":"2022","journal-title":"Diabet Foot J"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0027","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fphar.2015.00180","article-title":"Unexploited opportunities for phage therapy","volume":"6","author":"Oliveira","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0028","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13054-017-1709-y","article-title":"Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury\u2014a case report","volume":"21","author":"Jennes","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0029","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/dme.13973","article-title":"The cost of diabetic foot ulcers and amputations to the National Health Service in England","volume":"36","author":"Kerr","year":"2019","journal-title":"Diabet Med J Br Diabet Assoc"},{"key":"10.1016\/j.clinthera.2023.06.009_bib0030","unstructured":"FOI 0778 Tariff\/Cost of Bed [University Hospitals Birmingham website]. 2019. Available at: https:\/\/hgs.uhb.nhs.uk\/foi-0778-tariff-cost-of-bed. Accessed October 27, 2021."},{"key":"10.1016\/j.clinthera.2023.06.009_bib0031","unstructured":"Kerr M. Diabetic Foot Care in England: An Economic Study. 2017. Available at: https:\/\/diabetes-resources-production.s3-eu-west-1.amazonaws.com\/diabetes-storage\/migration\/pdf\/Diabetic%2520footcare%2520in%2520England%2C%2520An%2520economic%2520case%2520study%2520(January%25202017).pdf Accessed July 10, 2023."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823002023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823002023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:59:13Z","timestamp":1758963553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291823002023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0149291823002023"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.06.009","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phage Therapy for Diabetic Foot Infection: A Case Series","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}